Identification of phenazine analogue as a novel scaffold for thioredoxin reductase I inhibitors against Hep G2 cancer cell lines

Even though phenazines have been extensively reported as anticancer molecules, the molecular target of these compounds is severely lagging behind. Our study consequently focuses on the anticancer target of a phenazine analogue (CPUL1) for its potently antitumor activities in initial stage. Along wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Jianming, Wang, Linlin, Wu, Zhongxi, Wang, Zhixiang, Chen, Jun, Zhong, Yucheng, Jiang, Feng, Lu, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567043/
https://www.ncbi.nlm.nih.gov/pubmed/31179772
http://dx.doi.org/10.1080/14756366.2019.1624541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567043/
https://www.ncbi.nlm.nih.gov/pubmed/31179772
http://dx.doi.org/10.1080/14756366.2019.1624541

Ejemplares similares